In summary, this study highlights ALAS2 as a novel protector against NEC, with its downregulation exacerbating IEC death through oxidative stress and ferroptosis, while its overexpression preserves IEC viability via metabolic reprogramming and antioxidant defense (Figure 7). This evidence concerns the gene ALAS2 and necrotizing enterocolitis.